David Scharp
David Scharp
Prodo Laboratories, Scharp Technologies, & The Scharp-Lacy Research Institute
Email verificata su prodolabs.com - Home page
Titolo
Citata da
Citata da
Anno
Automated method for isolation of human pancreatic islets
C Ricordi, PE Lacy, EH Finke, BJ Olack, DW Scharp
Diabetes 37 (4), 413-420, 1988
14441988
Islet isolation assessment in man and large animals
C Ricordi, DWR Gray, BJ Hering, DB Kaufman, GL Warnock, ...
Acta diabetologia latina 27 (3), 185-195, 1990
5961990
Diabetes mellitus and exercise
American Diabetes Association
Diabetes care 25 (suppl 1), s64-s64, 2002
566*2002
Insulin independence after islet transplantation into type I diabetic patient
DW Scharp, PE Lacy, JV Santiago, CS McCullough, LG Weide, L Falqui, ...
Diabetes 39 (4), 515-518, 1990
4891990
Effect of homologous placental lactogens, prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: implication for…
TC Brelje, DW Scharp, PE Lacy, L Ogren, F Talamantes, M Robertson, ...
Endocrinology 132 (2), 879-887, 1993
4241993
Automated islet isolation from human pancreas
C Ricordi, PE Lacy, DW Scharp
Diabetes 38 (Supplement 1), 140-142, 1989
3971989
Effect of transplantation site on the results of pancreatic islet isografts in diabetic rats
CB Kemp, MJ Knight, DW Scharp, WF Ballinger, PE Lacy
Diabetologia 9 (6), 486-491, 1973
3761973
Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products
KE Dionne, DF Emerich, D Hoffman, PR Sanberg, L Christenson, ...
US Patent 6,083,523, 2000
3522000
Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products
KE Dionne, DF Emerich, D Hoffman, PR Sanberg, L Christenson, ...
US Patent 6,083,523, 2000
3522000
Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis: an observation in nonobese diabetic (NOD) mice
K Yamada, K Nonaka, T Hanafusa, A Miyazaki, H Toyoshima, S Tarui
Diabetes 31 (9), 749-753, 1982
3301982
Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients.
DW Scharp, PE Lacy, JV Santiago, CS McCullough, LG Weide, PJ Boyle, ...
Transplantation 51 (1), 76-85, 1991
2901991
The use of Ficoll in the preparation of viable islets of Langerhans from the rat pancreas
DW SCHARP, CB KEMP, MJ KNIGHT, WF BALLINGER, PE LACY
Transplantation 16 (6), 686-688, 1973
2681973
Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution
DW Scharp, P Marchetti
Advanced drug delivery reviews 67, 35-73, 2014
2062014
Transplantation of isolated pancreatic islets into the portal vein of diabetic rats
CB Kemp, MJ Knight, DW Scharp, PE Lacy, WF Ballinger
Nature 244 (5416), 447-447, 1973
2011973
Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects
DW Scharp, CJ Swanson, BJ Olack, PP Latta, OD Hegre, EJ Doherty, ...
Diabetes 43 (9), 1167-1170, 1994
1951994
A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice.
AM Davalli, Y Ogawa, C Ricordi, DW Scharp, S Bonner-Weir, GC Weir
Transplantation 59 (6), 817-820, 1995
1841995
A morphologic study of intrahepatic portal-vein islet isografts
RC Griffith, DW Scharp, BK Hartman, WF Ballinger, PE Lacy
Diabetes 26 (3), 201-214, 1977
1531977
Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
KE Dionne, DF Emerich, D Hoffman, PR Sanberg, L Christenson, ...
US Patent 5,800,828, 1998
1341998
Transplantation of islets of Langerhans in diabetic rhesus monkeys
DW Scharp, JJ Murphy, WT Newton, WF Ballinger, PE Lacy
Surgery 77 (1), 100-105, 1975
1321975
Islet immuno-isolation: the use of hybrid artificial organs to prevent islet tissue rejection
DW Scharp, NS Mason, RE Sparks
World journal of surgery 8 (2), 221-229, 1984
1291984
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20